Qixin Leng1, Jen-Hui Tsou1, Min Zhan2, Feng Jiang3. 1. Department of Pathology, The University of Maryland School of Medicine, 10 South Pine Street, MSTF 7th Floor, Baltimore, MD, 21201-1192, USA. 2. Department of Epidemiology and Public Health, University of Maryland School of Medicine, 660 W. Redwood St., Baltimore, MD, 21201, USA. 3. Department of Pathology, The University of Maryland School of Medicine, 10 South Pine Street, MSTF 7th Floor, Baltimore, MD, 21201-1192, USA. fjiang@som.umaryland.edu.
Abstract
PURPOSE: Fucosyltransferases (FUTs) catalyze fucosylation, which plays a central role in biological processes. Aberrant fucosylation is associated with malignant transformation. Here we investigated whether transcriptional levels of genes coding the FUTs in plasma could provide cell-free circulating biomarkers for lung cancer. METHODS: mRNA expression of all 13 Futs (Fut1-11, Pofut1, and Pofut2) was evaluated by PCR assay in 48 lung tumor tissues and the 48 matched noncancerous lung tissues, and plasma of 64 lung cancer patients and 32 cancer-free individuals to develop plasma Fut biomarkers. The developed plasma Fut biomarkers were validated in an independent cohort of 40 lung cancer patients and 20 controls for their diagnostic performance. RESULTS: Four of the 13 Futs showed a different transcriptional level in 48 lung tumor tissues compared with the 48 matched nonconscious tissues (all < 0.05). Two (Fut8, and Pofut1) of the four Futs had a higher plasma level in 64 lung cancer patients compared with 32 control subjects, and consistent with that in lung tissue specimens. Combined analysis of the two Futs produced 81% sensitivity and 86% specificity for diagnosis of lung cancer, and was independent of stage and histology of lung tumors. The diagnostic performance of the two plasma biomarkers was successfully validated in the different cohort of 40 lung cancer patients and 20 control individuals. CONCLUSION: The fucosylation genes may provide new circulating biomarkers for the early detection of lung cancer.
PURPOSE: Fucosyltransferases (FUTs) catalyze fucosylation, which plays a central role in biological processes. Aberrant fucosylation is associated with malignant transformation. Here we investigated whether transcriptional levels of genes coding the FUTs in plasma could provide cell-free circulating biomarkers for lung cancer. METHODS: mRNA expression of all 13 Futs (Fut1-11, Pofut1, and Pofut2) was evaluated by PCR assay in 48 lung tumor tissues and the 48 matched noncancerous lung tissues, and plasma of 64 lung cancerpatients and 32 cancer-free individuals to develop plasma Fut biomarkers. The developed plasma Fut biomarkers were validated in an independent cohort of 40 lung cancerpatients and 20 controls for their diagnostic performance. RESULTS: Four of the 13 Futs showed a different transcriptional level in 48 lung tumor tissues compared with the 48 matched nonconscious tissues (all < 0.05). Two (Fut8, and Pofut1) of the four Futs had a higher plasma level in 64 lung cancerpatients compared with 32 control subjects, and consistent with that in lung tissue specimens. Combined analysis of the two Futs produced 81% sensitivity and 86% specificity for diagnosis of lung cancer, and was independent of stage and histology of lung tumors. The diagnostic performance of the two plasma biomarkers was successfully validated in the different cohort of 40 lung cancerpatients and 20 control individuals. CONCLUSION: The fucosylation genes may provide new circulating biomarkers for the early detection of lung cancer.
Authors: F X Sullivan; R Kumar; R Kriz; M Stahl; G Y Xu; J Rouse; X J Chang; A Boodhoo; B Potvin; D A Cumming Journal: J Biol Chem Date: 1998-04-03 Impact factor: 5.157
Authors: Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner Journal: J Proteome Res Date: 2009-01 Impact factor: 4.466
Authors: A Jasmijn Hubers; Daniëlle A M Heideman; Yasushi Yatabe; Michelle D Wood; Justyna Tull; Miquel Tarón; Miquel A Molina; Clara Mayo; Jordi Bertran-Alamillo; Gerarda J M Herder; Remco Koning; Daoud Sie; Bauke Ylstra; Gerrit A Meijer; Peter J F Snijders; Birgit I Witte; Pieter E Postmus; Egbert F Smit; Erik Thunnissen Journal: Lung Cancer Date: 2013-08-05 Impact factor: 5.705
Authors: Jian Su; Jeipi Liao; Lu Gao; Jun Shen; Maria A Guarnera; Min Zhan; HongBin Fang; Sanford A Stass; Feng Jiang Journal: Oncotarget Date: 2016-02-02